Who has been buying Rokit Healthcare stock?

0 distinct insiders have filed 0 disclosed insider purchases in Rokit Healthcare (376900), most recently on 2026-09-11. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Rokit Healthcare have?

Rokit Healthcare has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-05-12 to 2026-09-11.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Rokit Healthcare 376900

Company

로킷헬스케어Rokit Healthcare

Insiders

Buys

Total Value

—

Avg Return

—

Last Filing

2026-09-11

Rokit Healthcare (376900) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Rokit Healthcare is dated 2025-05-12; the most recent is 2026-09-11.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-09-11	SELL	기타	이민구 Lee Min-gu	president	-28.5K	-	-	-
2026-05-15	BUY	주식매수청구권 행사	길윤기 Gil Yoongi	vice president	2.5K	₩68,600	-20.9%	₩172M ($119K)
2026-05-15	SELL	주식매수청구권 행사	이민구 Lee Min-gu	president	-2.5K	₩68,600	+20.9%	₩172M ($119K)
2026-05-15	BUY	주식매수청구권 행사	이민구 Lee Min-gu	president	2.5K	₩68,600	-20.9%	₩172M ($119K)
2026-04-21	SELL	주식매수청구권 행사	길윤기 Gil Yoongi	vice president	-2.5K	₩93,600	+42.0%	₩234M ($163K)
2026-03-31	BUY	신규선임	정철화 Cheolhwa Jeong	Outside Director	6.0K	₩124,800	-25.0%	₩749M ($520K)
2026-03-31	BUY	주식매수선택권	이영일 Youngil Lee	president	10.0K	₩124,800	-56.5%	₩1.2B ($867K)
2026-03-31	BUY	주식매수선택권	이민구 Lee Min-gu	president	10.0K	₩124,800	-56.5%	₩1.2B ($867K)
2025-11-03	BUY	주식매수선택권	이영일 Youngil Lee	president	10.0K	-	-	-
2025-11-03	BUY	주식매수선택권	이민구 Lee Min-gu	president	20.0K	-	-	-
2025-09-11	SELL	기타	길윤기 Gil Yoongi	vice president	-20.0K	-	-	-
2025-05-12	BUY	PROGRAM	이영일 Youngil Lee	president	30.0K	₩14,750	+329.1%	₩443M ($307K)
2025-05-12	BUY	PROGRAM	이민구 Lee Min-gu	president	1.5K	₩14,750	+329.1%	₩22M ($15K)
2025-05-12	BUY	PROGRAM	이민구 Lee Min-gu	president	63.5K	₩14,750	+329.1%	₩937M ($650K)
2025-05-12	BUY	PROGRAM	이상민 Sangmin Lee	Internal director	12.0K	₩14,750	+329.1%	₩177M ($123K)
2025-05-12	BUY	PROGRAM	이상민 Sangmin Lee	Internal director	10.0K	₩14,750	+329.1%	₩148M ($102K)
2025-05-12	BUY	PROGRAM	김재윤 Jaeyoon Kim	president	5.7K	₩14,750	+329.1%	₩84M ($58K)
2025-05-12	BUY	PROGRAM	김재윤 Jaeyoon Kim	president	31.3K	₩14,750	+329.1%	₩461M ($320K)
2025-05-12	BUY	PROGRAM	길윤기 Gil Yoongi	vice president	7.0K	₩14,750	+329.1%	₩103M ($72K)
2025-05-12	BUY	PROGRAM	길윤기 Gil Yoongi	vice president	50.0K	₩14,750	+329.1%	₩738M ($512K)
2025-05-12	BUY	PROGRAM	유석환 Yoo Seok-hwan	CEO	3.8M	₩14,750	+329.1%	₩55.9B ($38.8M)
2025-05-12	BUY	PROGRAM	김대영 Daeyoung Kim	president	24.0K	₩14,750	+329.1%	₩354M ($246K)
2025-05-12	BUY	PROGRAM	김대영 Daeyoung Kim	president	15.0K	₩14,750	+329.1%	₩221M ($154K)
2025-05-12	BUY	PROGRAM	이영일 Youngil Lee	president	10.0K	₩14,750	+329.1%	₩148M ($102K)

Frequently asked questions

Who has been buying Rokit Healthcare stock?: 0 distinct insiders have filed 0 disclosed insider purchases in Rokit Healthcare (376900), most recently on 2026-09-11. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Rokit Healthcare have?: Rokit Healthcare has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-05-12 to 2026-09-11.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.